Genetic Variation in CCL5 Signaling Genes and Triple Negative Breast Cancer: Susceptibility and Prognosis Implications

Triple-negative breast cancer (TNBC) accounts for ~15–20% of breast cancer (BC) and has a higher rate of early relapse and mortality compared to other subtypes. The Chemokine (C-C motif) ligand 5 (CCL5) and its signaling pathway have been linked to TNBC. We aimed to investigate the susceptibility an...

Descripción completa

Detalles Bibliográficos
Autores principales: Shan, Jingxuan, Chouchane, Aziz, Mokrab, Younes, Saad, Mohamad, Boujassoum, Salha, Sayaman, Rosalyn W., Ziv, Elad, Bouaouina, Noureddine, Remadi, Yasmine, Gabbouj, Sallouha, Roelands, Jessica, Ma, Xiaojing, Bedognetti, Davide, Chouchane, Lotfi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6915105/
https://www.ncbi.nlm.nih.gov/pubmed/31921621
http://dx.doi.org/10.3389/fonc.2019.01328

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6915105/
https://www.ncbi.nlm.nih.gov/pubmed/31921621
http://dx.doi.org/10.3389/fonc.2019.01328

Ejemplares similares